Graf Akcie GMED (Globus Medical Inc). Diskuze k akciím GMED. Aktuální informace GMED.

Základní informace o společnosti Globus Medical Inc (Akcie GMED)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 7.55B
Hodnota podniku (EV) 7.47B
Tržby 927.903M
EBITDA 244.597M
Zisk 184.047M
Růst v tržbách Q/Q 68.56 %
Růst v tržbách Y/Y 24.15 %
P/E (Cena vůči ziskům) 41.31
Forward P/E N/A
EV/Sales 8.05
EV/EBITDA 30.55
EV/EBIT 35.55
PEG 2.52
Price/Sales 8.14
P/FCF 37.26
Price/Book 5.02
Účetní hodnota na akcii 15.24
Hotovost na akcii 4.32
FCF vůči ceně 2.68 %
Počet zaměstnanců 2,200
Tržba na zaměstnance 421.774k
Profit margin 12.96 %
Operating margin 22.52 %
Gross margin 72.44 %
EBIT margin 22.65 %
EBITDA margin 26.36 %
EPS - Zisk na akcii 1.85
EPS - Kvartální růst 700.00 %
EPS - Očekávaný růst příští rok -8.16 %
Return on assets 10.84 %
Return on equity 12.02 %
ROIC 6.97 %
ROCE 12.36 %
Dluhy/Equity 0.11
Čistý dluh/EBITDA -6.95
Current ratio 6.86
Quick Ratio 5.08
Volatilita 2.42
Beta 1.00
RSI 43.48
Cílová cena analytiků 61
Známka akcie (dle analytiků) 1.87
Insider ownership 1.11 %
Institutional ownership 90.54 %
Počet akcií 100.891M
Procento shortovaných akcií 1.99 %
Short ratio 3.19 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie GMED

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$789.042$785.368$712.969$635.977$563.994$544.753
Cost Of Goods Sold$217.463$179.975$159.41$150.453$134.705$132.333
Gross Profit$571.579$605.393$553.559$485.524$429.289$412.42
Research And Development Expenses$84.519$60.073$55.496$43.679$44.532$36.312
SG&A Expenses$354.757$354.757$311.591$267.817$222.156$210.241
Other Operating Income Or Expenses$-4.039$-4.765$-7.559$-4.279$-4.982$7.916
Operating Expenses$677.609$613.379$543.644$474.137$409.853$372.531
Operating Income$111.433$171.989$169.325$161.84$154.141$172.222
Total Non-Operating Income/Expense$14.466$17.957$19.28$8.088$3.138$0.583
Pre-Tax Income$125.899$189.946$188.605$169.928$157.279$172.805
Income Taxes$23.614$34.736$32.131$62.58$52.938$60.021
Income After Taxes$102.285$155.21$156.474$107.348$104.341$112.784
Other Income------
Income From Continuous Operations$102.285$155.21$156.474$107.348$104.341$112.784
Income From Discontinued Operations------
Net Income$102.285$155.21$156.474$107.348$104.341$112.784
EBITDA$174.894$223.634$212.632$207.094$200.452$199.66
EBIT$111.433$171.989$169.325$161.84$154.141$172.222
Basic Shares Outstanding999998969695
Shares Outstanding101102101989696
Basic EPS$1.04$1.57$1.60$1.12$1.09$1.19
EPS - Earnings Per Share$1.01$1.52$1.54$1.10$1.08$1.17
# 2020 2019 2018 2017 2016 2015
Current Ratio6.80316.1716.56156.66516.43086.5884
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin72.439677.08477.641476.34376.115975.7077
Operating Margin14.122621.899223.749325.447527.330331.6147
EBIT Margin14.122621.899223.749325.447527.330331.6147
EBITDA Margin22.165428.475129.823532.563135.541536.6515
Pre-Tax Profit Margin15.955924.185626.453526.719227.886631.7217
Net Profit Margin12.963219.762721.946816.879218.500420.7037
Asset Turnover0.46980.51260.54820.58970.6080.6531
Inventory Turnover Ratio0.9490.91681.21451.38781.19531.2572
Receiveable Turnover5.32784.83534.9395.07195.88826.3084
Days Sales In Receivables68.50975.486673.902271.965661.987957.859
ROE - Return On Equity6.790511.06713.198811.092212.539815.7668
Return On Tangible Equity8.100912.989816.057514.028215.703519.1121
ROA - Return On Assets6.090310.130712.03039.953411.24813.5216
ROI - Return On Investment6.790511.067113.198811.092212.539815.7668
Book Value Per Share15.106214.049112.026810.01248.67387.5044
Operating Cash Flow Per Share0.2827-0.10670.16790.0920.24210.4614
Free Cash Flow Per Share0.346-0.26060.1522-0.00790.34630.1923